Rezolute (RZLT) Return on Capital Employed (2013 - 2026)
Rezolute (RZLT) reported Return on Capital Employed of 70.17% for Q1 2026, up 1289.0% on a YoY basis from 5.05% in Q1 2025, and down 8.57% sequentially from 64.63% in Q4 2025.
Rezolute (RZLT) Return on Capital Employed (2013 - 2026) Analysis & Trends
Rezolute (RZLT) has 14 years of Return on Capital Employed data on file, last reported at 70.17% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 1289.0% year-over-year to 70.17%; the trailing twelve-month figure through Mar 2026 stood at 70.17% (up 1289.0% YoY), and the FY2025 full-year result was 56.18%, up 318.0% from the prior year.
- Return on Capital Employed fell to 70.17% in Q1 2026, from 64.63% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 29.26% in Q3 2022 to a low of 83.07% in Q1 2025.
- A 5-year average of 56.21% and a median of 59.5% in 2024 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed soared 4140 bps in 2022 and tumbled 3147 bps in 2024, its largest moves.
- Tracing RZLT's Return on Capital Employed over 5 years: stood at 31.79% in 2022, then sank by 97 bps to 62.76% in 2023, then dropped by 9 bps to 68.47% in 2024, then grew by 6 bps to 64.63% in 2025, then fell by 9 bps to 70.17% in 2026.
- Business Quant data shows RZLT's Return on Capital Employed at 70.17% in Q1 2026, 64.63% in Q4 2025, and 52.76% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Rezolute | 31,153.77 | 31,153.77 | - | -70.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.17% |
| Dec 31, 2025 | -64.63% |
| Sep 30, 2025 | -52.76% |
| Jun 30, 2025 | -64.85% |
| Mar 31, 2025 | -83.07% |
| Dec 31, 2024 | -68.47% |
| Sep 30, 2024 | -59.50% |
| Jun 30, 2024 | -69.98% |
| Mar 31, 2024 | -69.96% |
| Dec 31, 2023 | -62.76% |
| Sep 30, 2023 | -55.49% |
| Jun 30, 2023 | -45.24% |
| Mar 31, 2023 | -38.49% |
| Dec 31, 2022 | -31.79% |
| Sep 30, 2022 | -29.26% |
| Jun 30, 2022 | -38.55% |
| Mar 31, 2022 | -50.52% |
| Dec 31, 2021 | -58.35% |
| Sep 30, 2021 | -70.66% |
| Jun 30, 2021 | -63.94% |